Spain’s SpliceBio Secures Sanofi and Roche Support In $135m Financing

Series B cash will be used to advance its Stargardt disease gene therapy.

Vila-Perelló 1200
Miquel Vila-Perelló • Source: SpliceBio

More from Gene Therapies

More from Therapy Areas